- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Cardiovascular Disease
Increased Frequency of Menopause Symptoms Could Signal Increased Risk of CV Events
January 23, 2021
Data from an analysis of more than 3k women indicate increased frequency of vasomotor menopausal symptoms was associated with a 52% greater risk of incident cardiovascular disease.
No Limit to Cardiovascular Disease Risk Reduction Derived from Exercise, Study Suggests
January 16, 2021
An analysis of data from the UK Biobank cohort offers an overview of the risk reduction for cardiovascular disease derived from various levels and measurements of physical activity.
Excess Cardiac Deaths from Avoiding Emergency Departments Remain a Cause for Concern
January 07, 2021
A study from UCL is providing clinicians with an estimate of excess cardiac deaths that occurred as a result of nonattendance to emergency department visits during the March 2020 peak of the pandemic.
CTA Scans Detail Impact of Intensive Lifestyle Interventions on Plaque Progression in ASCVD
January 05, 2021
A single-center trial from Europe is comparing plaque progression using CTA scans of patients randomized to intensive lifestyle intervention versus optimized medical therapy alone.
Physician Perspective: AHA Guidelines on Managing CVD Risk During Menopause
December 20, 2020
Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.
Intensive Glucose, Blood Pressure Control Reduces Risk of Cardiovascular Autonomic Neuropathy
December 17, 2020
An analysis of more than 7k patients with CAN data from the ACCORD trial suggest intensive blood pressure and blood glucose control could reduce risk of cardiovascular autonomic neuropathy.
Study Examines How Age at Diabetes Diagnosis Predicts Risk of Complications Later in Life
December 15, 2020
An analysis of more than 25 studies with more than 1 million patients is giving an overview of how the timing of a diabetes diagnosis can impact risk of complications later in life.
Weight Loss Surgery Bests Medical Therapy for Reducing CVD in Obese Teens
December 13, 2020
An analysis of 2 major studies is comparing the effects of bariatric surgery vs standard medical therapy on risk of cardiovascular disease events in obese teens with type 2 diabetes.
SGLT2 Inhibitors for Primary Prevention: The Future of Care?
December 11, 2020
A resident from Penn State Hershey Medical Center offers perspective on the idea of using SGLT2 inhibitors for primary prevention in patients with type 2 diabetes.
Gender Gaps in Care Following Heart Attack Still Persist
December 04, 2020
An analysis of data over a 12-year period details the disparities in outcomes following first heart attack among female versus male patients.
Greater Long-Term HbA1c Variability Increases Risk of All-Cause, Cardiovascular Death
December 02, 2020
An analysis of the Look AHEAD study by investigators at Johns Hopkins details associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.
Increased Sedentary Behavior Raises Heart Failure Risk in Women
November 29, 2020
An analysis of data from the Women's Health Initiative suggests spending more than 6.5 hours engaged in sedentary behaviors each day was linked to a 42% increase in risk of heart failure in older women.
FIDELIO-DKD Analysis Suggests Finerenone Use Could Reduce Cardiovascular Events
November 23, 2020
An analysis of cardiovascular outcomes from FIDELIO-DKD suggest finerenone use was associated with a 14% reduction in negative cardiovascular outcomes.
Comparing Cost-Effectiveness of Antihyperglycemic Agents with Cardiovascular Benefit
November 21, 2020
In a recent column Gregory Weiss, MD, uses studies from AHA Scientific Sessions 2020 to compare the cost-effectiveness of antihyperglycemic agents for reducing cardiovascular events.
High Blood Pressure Complications On the Rise Pregnant Women
November 20, 2020
An analysis of CDC data presented at AHA Scientific Sessions 2020 suggests rates of high blood pressure complications among pregnant women nearly doubled during a period lasting from 2008-2017.
Muthiah Vaduganathan, MD, MPH: Identifying Dysglycemia in STEMI Patients
November 19, 2020
An analysis from AHA 2020 suggests an HbA1c screening protocol doubled the proportion of patients with known dysglycemia when treating patients with ST-elevation myocardial infarction.
Sotagliflozin Makes Waves at AHA 2020 with Phase 3 SOLOIST and SCORED
November 17, 2020
Data from a pair of phase 3 trials detail the effects of sotagliflozin in patients with type 2 diabetes and other comorbidities, such as worsening heart failure and chronic kidney disease.
Semaglutide Analysis Indicates Effect on MACE Present Regardless of Triglyceride Levels
November 16, 2020
Pooled analysis of SUSTAIN 6 and PIONEER 6 trials indicates the impact of semaglutide impact on MACE was present regardless of baseline triglyceride levels among diabetic patients.
Professor John McMurray: Improving SGLT2 Inhibitor Prescribing Rates
November 16, 2020
Professor John McMurray explains why he is not as displeased as some colleagues are with the uptake of SGLT2 inhibitor prescribing rates for patients with heart failure or chronic kidney disease.
Mass General Study Details How Premature Menopause Impacts Heart Health
November 12, 2020
An analysis of blood samples from more than 19k women offers greater insight into the relationship between premature menopause and cardiovascular disease risk in postmenopausal women.